News
Some Indonesian netizens oppose the clinical trial of a tuberculosis (TB) vaccine candidate in Indonesia, whose development ...
7h
NDTV Profit on MSNStocks To Watch Today: NBCC, BEL, Pfizer, Power Grid, DelhiveryNBCC India Ltd., Bharat Electronics Ltd., Pfizer Ltd., Power Grid Corp. and Delhivery Ltd. among others are set to see action ...
The pharma company said it expects more approvals through the year following positive results from a Phase 3 trial.
The clinical trial for the potential vaccine, VLA15, began in August 2022. Stage 3 trials got underway in late 2023, ...
Children with asthma experienced fewer exacerbations and better control with dupilumab regardless of the duration of their ...
Pharmaceutical share prices fell last Monday, after US President Donald Trump vowed to reduce drug prices in the USA by as ...
Stocks like Zen Technologies, Arvind Fashions, Galaxy Surfactants, KRBL, Kalpataru Projects International, IOL Chemicals, ...
6h
India Today on MSNStocks to watch on May 19: Bajaj Auto, Delhivery, Dr Reddy's, JSW Steel, BELMany companies will be in focus due to their earnings and key updates, such as Power Grid Corporation of India, Bharat ...
(Alliance News) - GSK PLC on Monday said it has received approval in Japan for Blenrep combinations in the treatment of adults with relapsed or refractory multiple myeloma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results